Regulation of P2X7 nucleotide receptor function in human monocytes by extracellular ions and receptor density

被引:103
作者
Gudipaty, L
Humphreys, BD
Buell, G
Dubyak, GR
机构
[1] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA
[2] Serona Pharmceut Res Inst, Geneva, Switzerland
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2001年 / 280卷 / 04期
关键词
macrophage; extracellular ATP; inflammation; ligand-gated ion channel;
D O I
10.1152/ajpcell.2001.280.4.C943
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
P2X receptors function as ATP-gated cation channels. The P2X(7) receptor subtype is distinguished from other P2X family members by a very low affinity for extracellular ATP (millimolar EC50) and its ability to trigger induction of nonselective pores on repeated or prolonged stimulation. Previous studies have indicated that certain P2X(7) receptor-positive cell types, such as human blood monocytes and murine thymocytes, lack this pore-forming response. In the present study we compared pore formation in response to P2X(7) receptor activation in human blood monocytes with that in macrophages derived from these monocytes by in vitro tissue culture. ATP induced nonselective pores in macrophages but not in freshly isolated monocytes when both cell types were identically stimulated in standard NaCl-based salines. However, ion substitution studies revealed that replacement of extracellular Na+ and Cl- with K+ and nonhalide anions strongly facilitated ATP-dependent pore formation in monocytes. These ionic conditions also resulted in increased agonist affinity, such that 30-100 muM ATP was sufficient for activation of nonselective pores by P2X(7) receptors. Comparison of P2X(7) receptor expression in blood monocytes with that in macrophages indicated no differences in steady-state receptor mRNA levels but significant increases (up to 10-fold) in the amount of immunoreactive P2X(7) receptor protein at the cell surface of macrophages. Thus ability of ATP to activate nonselective pores in cells that natively express P2X(7) receptors can be modulated by receptor subunit density at the cell surface and ambient levels of extracellular Na+ and Cl-. These mechanisms may prevent adventitious P2X(7) receptor activation in monocytes until these proinflammatory leukocytes migrate to extravascular sites of tissue damage.
引用
收藏
页码:C943 / C953
页数:11
相关论文
共 40 条
[1]  
BAZIL V, 1991, J IMMUNOL, V147, P1567
[2]   Blockade of human P2X7 receptor function with a monoclonal antibody [J].
Buell, G ;
Chessell, IP ;
Michel, AD ;
Colo, G ;
Salazzo, M ;
Herren, S ;
Gretener, D ;
Grahames, C ;
Kaur, R ;
Kosco-Vilbois, MH ;
Humphrey, PPA .
BLOOD, 1998, 92 (10) :3521-3528
[3]   Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X(7) receptor [J].
Chiozzi, P ;
Sanz, JM ;
Ferrari, D ;
Falzoni, S ;
Aleotti, A ;
Buell, GN ;
Collo, G ;
DiVirgilio, F .
JOURNAL OF CELL BIOLOGY, 1997, 138 (03) :697-706
[4]   P2Z/P2X7 receptor-dependent apoptosis of dendritic cells [J].
Coutinho-Silva, R ;
Persechini, PM ;
Bisaggio, RD ;
Perfettini, JL ;
Neto, ACTD ;
Kanellopoulos, JM ;
Motta-Ly, I ;
Dautry-Varsat, A ;
Ojcius, DM .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1999, 276 (05) :C1139-C1147
[5]   PROPERTIES OF FC RECEPTOR ON MACROPHAGES AND MONOCYTES [J].
DORRINGTON, KJ .
IMMUNOLOGICAL COMMUNICATIONS, 1976, 5 (04) :263-280
[6]  
DUBYAK GR, 1996, DRUG DEVELOP RES, V38, P1
[7]  
Evans RJ, 1998, P2 NUCLEOTIDE RECEPT, P43
[8]   THE PURINERGIC P-2Z RECEPTOR OF HUMAN MACROPHAGE CELLS - CHARACTERIZATION AND POSSIBLE PHYSIOLOGICAL-ROLE [J].
FALZONI, S ;
MUNERATI, M ;
FERRARI, D ;
SPISANI, S ;
MORETTI, S ;
DIVIRGILIO, F .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (03) :1207-1216
[9]   In vitro differentiation of human monocytes to macrophages: Change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors [J].
Gantner, F ;
Kupferschmidt, R ;
Schudt, C ;
Wendel, A ;
Hatzelmann, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (02) :221-231
[10]   ATP, a partial agonist for the P2Z receptor of human lymphocytes [J].
Gargett, CE ;
Cornish, JE ;
Wiley, JS .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (05) :911-917